Polymorphisms in TGF-β1 gene and the risk of lung cancer

Hyo Gyoung Kang, Myung Hwa Chae, Jung Min Park, Eun Jin Kim, Jae Hyung Park, Sin Kam, Sung Ick Cha, Chang Ho Kim, Rang Woon Park, Sun Hee Park, Yong Lim Kim, In-San Kim, Tae Hoon Jung, Jae Yong Park

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Background: Transforming growth factor-β1 (TGF-β1) functions as a suppressor of tumor initiation by inhibiting cellular proliferation or by promoting cellular differentiation or apoptosis in the early phase of cancer development. Variations in the DNA sequence in the TGF-β1 gene may lead to altered TGF-β1 production and/or activity, and so this can modulate an individual's susceptibility to lung cancer. To test this hypothesis, we investigated the association of the TGF-β1 -509C > T and 869T > C (L10P) polymorphisms and their haplotypes with the risk of lung cancer in a Korean population. Methods: The TGF-β1 genotypes were determined in 432 lung cancer patients and in 432 healthy control subjects who were frequency-matched for age and gender. The TGF-β1 haplotypes were predicted using a Bayesian algorithm in the Phase program. Results: Individuals with at least one -509T allele were at a significantly decreased risk of adenocarcinoma (AC) and small cell carcinoma (SM), as compared with carriers with the -509CC genotype [adjusted odds ratio (OR), 0.63; 95% confidence interval (CI), 0.42-0.96; P = 0.04; and adjusted OR, 0.45; 95% CI, 0.27-0.76; P = 0.002; respectively]. For the 869T > C polymorphism, the combined TC + CC genotype was associated with a significantly decreased risk of SM compared with the TT genotype (adjusted OR, 0.52; 95% CI, 0.31-0.88; P = 0.01). Consistent with the results of the genotyping analyses, the -509T/869C haplotype was associated with a significantly decreased risk of AC and SM as compared with the -509C/869T haplotype (adjusted OR, 0.75; 95% CI, 0.57-0.98; P = 0.04; and adjusted OR, 0.67; 95% CI, 0.47-0.96; P = 0.02; respectively). Conclusion: The TGF-β1 -509C > T and 869T > C polymorphisms and their haplotypes may contribute to genetic susceptibility to AC and SM of the lung.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalLung Cancer
Volume52
Issue number1
DOIs
Publication statusPublished - 2006 Apr 1
Externally publishedYes

Fingerprint

Transforming Growth Factors
Lung Neoplasms
Haplotypes
Odds Ratio
Confidence Intervals
Genes
Genotype
Adenocarcinoma
Small Cell Carcinoma
Genetic Predisposition to Disease
Neoplasms
Healthy Volunteers
Alleles
Cell Proliferation
Apoptosis
Population

Keywords

  • Genetic susceptibility
  • Lung cancer
  • Polymorphism
  • TGF-β1

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Kang, H. G., Chae, M. H., Park, J. M., Kim, E. J., Park, J. H., Kam, S., ... Park, J. Y. (2006). Polymorphisms in TGF-β1 gene and the risk of lung cancer. Lung Cancer, 52(1), 1-7. https://doi.org/10.1016/j.lungcan.2005.11.016

Polymorphisms in TGF-β1 gene and the risk of lung cancer. / Kang, Hyo Gyoung; Chae, Myung Hwa; Park, Jung Min; Kim, Eun Jin; Park, Jae Hyung; Kam, Sin; Cha, Sung Ick; Kim, Chang Ho; Park, Rang Woon; Park, Sun Hee; Kim, Yong Lim; Kim, In-San; Jung, Tae Hoon; Park, Jae Yong.

In: Lung Cancer, Vol. 52, No. 1, 01.04.2006, p. 1-7.

Research output: Contribution to journalArticle

Kang, HG, Chae, MH, Park, JM, Kim, EJ, Park, JH, Kam, S, Cha, SI, Kim, CH, Park, RW, Park, SH, Kim, YL, Kim, I-S, Jung, TH & Park, JY 2006, 'Polymorphisms in TGF-β1 gene and the risk of lung cancer', Lung Cancer, vol. 52, no. 1, pp. 1-7. https://doi.org/10.1016/j.lungcan.2005.11.016
Kang HG, Chae MH, Park JM, Kim EJ, Park JH, Kam S et al. Polymorphisms in TGF-β1 gene and the risk of lung cancer. Lung Cancer. 2006 Apr 1;52(1):1-7. https://doi.org/10.1016/j.lungcan.2005.11.016
Kang, Hyo Gyoung ; Chae, Myung Hwa ; Park, Jung Min ; Kim, Eun Jin ; Park, Jae Hyung ; Kam, Sin ; Cha, Sung Ick ; Kim, Chang Ho ; Park, Rang Woon ; Park, Sun Hee ; Kim, Yong Lim ; Kim, In-San ; Jung, Tae Hoon ; Park, Jae Yong. / Polymorphisms in TGF-β1 gene and the risk of lung cancer. In: Lung Cancer. 2006 ; Vol. 52, No. 1. pp. 1-7.
@article{197daeb6296b4a83adae83947dd0d416,
title = "Polymorphisms in TGF-β1 gene and the risk of lung cancer",
abstract = "Background: Transforming growth factor-β1 (TGF-β1) functions as a suppressor of tumor initiation by inhibiting cellular proliferation or by promoting cellular differentiation or apoptosis in the early phase of cancer development. Variations in the DNA sequence in the TGF-β1 gene may lead to altered TGF-β1 production and/or activity, and so this can modulate an individual's susceptibility to lung cancer. To test this hypothesis, we investigated the association of the TGF-β1 -509C > T and 869T > C (L10P) polymorphisms and their haplotypes with the risk of lung cancer in a Korean population. Methods: The TGF-β1 genotypes were determined in 432 lung cancer patients and in 432 healthy control subjects who were frequency-matched for age and gender. The TGF-β1 haplotypes were predicted using a Bayesian algorithm in the Phase program. Results: Individuals with at least one -509T allele were at a significantly decreased risk of adenocarcinoma (AC) and small cell carcinoma (SM), as compared with carriers with the -509CC genotype [adjusted odds ratio (OR), 0.63; 95{\%} confidence interval (CI), 0.42-0.96; P = 0.04; and adjusted OR, 0.45; 95{\%} CI, 0.27-0.76; P = 0.002; respectively]. For the 869T > C polymorphism, the combined TC + CC genotype was associated with a significantly decreased risk of SM compared with the TT genotype (adjusted OR, 0.52; 95{\%} CI, 0.31-0.88; P = 0.01). Consistent with the results of the genotyping analyses, the -509T/869C haplotype was associated with a significantly decreased risk of AC and SM as compared with the -509C/869T haplotype (adjusted OR, 0.75; 95{\%} CI, 0.57-0.98; P = 0.04; and adjusted OR, 0.67; 95{\%} CI, 0.47-0.96; P = 0.02; respectively). Conclusion: The TGF-β1 -509C > T and 869T > C polymorphisms and their haplotypes may contribute to genetic susceptibility to AC and SM of the lung.",
keywords = "Genetic susceptibility, Lung cancer, Polymorphism, TGF-β1",
author = "Kang, {Hyo Gyoung} and Chae, {Myung Hwa} and Park, {Jung Min} and Kim, {Eun Jin} and Park, {Jae Hyung} and Sin Kam and Cha, {Sung Ick} and Kim, {Chang Ho} and Park, {Rang Woon} and Park, {Sun Hee} and Kim, {Yong Lim} and In-San Kim and Jung, {Tae Hoon} and Park, {Jae Yong}",
year = "2006",
month = "4",
day = "1",
doi = "10.1016/j.lungcan.2005.11.016",
language = "English",
volume = "52",
pages = "1--7",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Polymorphisms in TGF-β1 gene and the risk of lung cancer

AU - Kang, Hyo Gyoung

AU - Chae, Myung Hwa

AU - Park, Jung Min

AU - Kim, Eun Jin

AU - Park, Jae Hyung

AU - Kam, Sin

AU - Cha, Sung Ick

AU - Kim, Chang Ho

AU - Park, Rang Woon

AU - Park, Sun Hee

AU - Kim, Yong Lim

AU - Kim, In-San

AU - Jung, Tae Hoon

AU - Park, Jae Yong

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Background: Transforming growth factor-β1 (TGF-β1) functions as a suppressor of tumor initiation by inhibiting cellular proliferation or by promoting cellular differentiation or apoptosis in the early phase of cancer development. Variations in the DNA sequence in the TGF-β1 gene may lead to altered TGF-β1 production and/or activity, and so this can modulate an individual's susceptibility to lung cancer. To test this hypothesis, we investigated the association of the TGF-β1 -509C > T and 869T > C (L10P) polymorphisms and their haplotypes with the risk of lung cancer in a Korean population. Methods: The TGF-β1 genotypes were determined in 432 lung cancer patients and in 432 healthy control subjects who were frequency-matched for age and gender. The TGF-β1 haplotypes were predicted using a Bayesian algorithm in the Phase program. Results: Individuals with at least one -509T allele were at a significantly decreased risk of adenocarcinoma (AC) and small cell carcinoma (SM), as compared with carriers with the -509CC genotype [adjusted odds ratio (OR), 0.63; 95% confidence interval (CI), 0.42-0.96; P = 0.04; and adjusted OR, 0.45; 95% CI, 0.27-0.76; P = 0.002; respectively]. For the 869T > C polymorphism, the combined TC + CC genotype was associated with a significantly decreased risk of SM compared with the TT genotype (adjusted OR, 0.52; 95% CI, 0.31-0.88; P = 0.01). Consistent with the results of the genotyping analyses, the -509T/869C haplotype was associated with a significantly decreased risk of AC and SM as compared with the -509C/869T haplotype (adjusted OR, 0.75; 95% CI, 0.57-0.98; P = 0.04; and adjusted OR, 0.67; 95% CI, 0.47-0.96; P = 0.02; respectively). Conclusion: The TGF-β1 -509C > T and 869T > C polymorphisms and their haplotypes may contribute to genetic susceptibility to AC and SM of the lung.

AB - Background: Transforming growth factor-β1 (TGF-β1) functions as a suppressor of tumor initiation by inhibiting cellular proliferation or by promoting cellular differentiation or apoptosis in the early phase of cancer development. Variations in the DNA sequence in the TGF-β1 gene may lead to altered TGF-β1 production and/or activity, and so this can modulate an individual's susceptibility to lung cancer. To test this hypothesis, we investigated the association of the TGF-β1 -509C > T and 869T > C (L10P) polymorphisms and their haplotypes with the risk of lung cancer in a Korean population. Methods: The TGF-β1 genotypes were determined in 432 lung cancer patients and in 432 healthy control subjects who were frequency-matched for age and gender. The TGF-β1 haplotypes were predicted using a Bayesian algorithm in the Phase program. Results: Individuals with at least one -509T allele were at a significantly decreased risk of adenocarcinoma (AC) and small cell carcinoma (SM), as compared with carriers with the -509CC genotype [adjusted odds ratio (OR), 0.63; 95% confidence interval (CI), 0.42-0.96; P = 0.04; and adjusted OR, 0.45; 95% CI, 0.27-0.76; P = 0.002; respectively]. For the 869T > C polymorphism, the combined TC + CC genotype was associated with a significantly decreased risk of SM compared with the TT genotype (adjusted OR, 0.52; 95% CI, 0.31-0.88; P = 0.01). Consistent with the results of the genotyping analyses, the -509T/869C haplotype was associated with a significantly decreased risk of AC and SM as compared with the -509C/869T haplotype (adjusted OR, 0.75; 95% CI, 0.57-0.98; P = 0.04; and adjusted OR, 0.67; 95% CI, 0.47-0.96; P = 0.02; respectively). Conclusion: The TGF-β1 -509C > T and 869T > C polymorphisms and their haplotypes may contribute to genetic susceptibility to AC and SM of the lung.

KW - Genetic susceptibility

KW - Lung cancer

KW - Polymorphism

KW - TGF-β1

UR - http://www.scopus.com/inward/record.url?scp=33644779564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644779564&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2005.11.016

DO - 10.1016/j.lungcan.2005.11.016

M3 - Article

C2 - 16499994

AN - SCOPUS:33644779564

VL - 52

SP - 1

EP - 7

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 1

ER -